The Advanced Research Projects Agency for Health (ARPA-H) is offering a funding opportunity for the Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) Program, aimed at advancing innovative solutions in regenerative medicine. This initiative anticipates multiple awards and seeks proposals that align with the program's objectives, with a focus on developing nanotechnology-based tissue solutions. The program is significant for its potential to enhance healthcare outcomes through cutting-edge research and development in science and technology. Interested applicants should note that the proposal due date is August 20, 2024, at 9:00 AM ET, and can contact the PRINT Program Team at PRINT@ARPA-H.gov for further information. Additional details can be found on the SAM.gov posting.